Holen Sie sich die Stockscreener-App
1.03
4.23%
0.0418
Schlusskurs vom Vortag:
$0.9882
Offen:
$1
24-Stunden-Volumen:
8,894
Relative Volume:
0.02
Marktkapitalisierung:
$12.44M
Einnahmen:
$248.40K
Nettoeinkommen (Verlust:
$-3.05M
KGV:
-3.9448
EPS:
-0.2611
Netto-Cashflow:
$-3.30M
1W Leistung:
+0.00%
1M Leistung:
-1.90%
6M Leistung:
-51.18%
1J Leistung:
-56.72%
1-Tages-Spanne:
$0.9619
$1.06
1-Wochen-Bereich:
$0.9619
$1.06
52-Wochen-Spanne:
$0.7282
$3.68
Cytomed Therapeutics Ltd Stock (GDTC) Company Profile
Firmenname
Cytomed Therapeutics Ltd
Sektor
Branche
Telefon
-
Adresse
-
Compare GDTC vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GDTC
Cytomed Therapeutics Ltd
|
1.06 | 11.60M | 248.40K | -3.05M | -3.30M | -0.2611 |
VRTX
Vertex Pharmaceuticals Inc
|
433.53 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.13 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
747.05 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.56 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.57 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Cytomed Therapeutics Ltd Aktie (GDTC) Neueste Nachrichten
GDTC Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Rising R&D loss as CytoMed (NASDAQ: GDTC) advances γδ T cell therapies - Stock Titan
CytoMed Therapeutics (NASDAQ: GDTC) flags losses and funding needs in 2025 report - Stock Titan
Stop Loss: Why is CytoMed Therapeutics Limited stock going upWeekly Trade Analysis & Community Consensus Trade Alerts - baoquankhu1.vn
AI Stocks: Can CytoMed Therapeutics Limited withstand a market correctionMarket Performance Recap & Scalable Portfolio Growth Ideas - baoquankhu1.vn
GDTC SEC FilingsCytoMed Therapeutics Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Interview with the Chairman: CytoMed Therapeutics Ltd. (NASDAQ:GDTC) - The Wall Street Transcript
GDTC Technical Analysis & ETF Price Forecast - Intellectia AI
GDTC Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
GDTC Should I Buy - Intellectia AI
GDTCCytoMed Therapeutics Ltd Latest Stock News & Market Updates - Stock Titan
CytoMed Therapeutics (NASDAQ:GDTC) Trading Up 1% – Still a Buy? - Defense World
Insider Sell: What analysts say about CytoMed Therapeutics Limited stock2025 Year in Review & Real-Time Buy Signal Notifications - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
CytoMed Therapeutics And 2 More Penny Stocks With Promising Prospects - Yahoo Finance
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Cytomed Therapeutics refutes ‘misleading’ claims, reaffirms clinical progress - Yahoo Finance
Published on: 2026-01-29 21:36:08 - baoquankhu1.vn
Cancer cell therapy company hits back at claims about its first human trial - Stock Titan
CytoMed Therapeutics Refutes Misleading Claims and Reaffirms Clinical Progress - Yahoo Finance
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
CytoMed Therapeutics updates on cell therapy pipeline and trials By Investing.com - Investing.com Nigeria
CytoMed Therapeutics updates on cell therapy pipeline and trials - Investing.com
Biotech seeks investor views on share-based access to cell therapy - Stock Titan
CytoMed Therapeutics’ new year update and seeks shareholders’ feedback on proposal to improve shareholder value for their patient capital - Yahoo Finance
How buybacks impact CytoMed Therapeutics Limited stock valueExit Point & Risk Controlled Daily Plans - Улправда
Is CytoMed Therapeutics Limited stock attractive after correctionJuly 2025 Technicals & Expert-Curated Trade Recommendations - DonanımHaber
How CytoMed Therapeutics Limited (F98) stock performs in volatility spikes2025 Growth vs Value & Fast Entry and Exit Trade Plans - Улправда
Is CytoMed Therapeutics Limited stock a smart buy before Fed meeting2025 Valuation Update & Daily Profit Maximizing Trade Tips - Улправда
CytoMed Therapeutics (NASDAQ:GDTC) Trading Up 7.2% – Here’s Why - Defense World
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
CytoMed stock jumps after announcing clinical trial partnership in Malaysia By Investing.com - Investing.com South Africa
CytoMed stock jumps after announcing clinical trial partnership in Malaysia - Investing.com India
CytoMed Therapeutics enters clinical trial agreement with Malaysian hospital - Investing.com
CytoMed Therapeutics enters clinical trial agreement with Malaysian hospital By Investing.com - Investing.com South Africa
CytoMed Therapeutics (NASDAQ: GDTC) plans first-in-human gamma delta T cell trial in Malaysia - Stock Titan
CytoMed Therapeutics (NASDAQ: GDTC) to run first-in-human Malaysia trial of donor-derived γδ T cells - Stock Titan
CytoMed Therapeutics (GDTC) Stock Analysis Report | Financials & Insights - Benzinga
Why CytoMed Therapeutics Limited (F98) stock appears on watchlists2025 Price Momentum & Reliable Trade Execution Plans - Newser
Will CytoMed Therapeutics Limited (F98) stock benefit from Fed rate cuts2025 Short Interest & Intraday High Probability Setup Alerts - Newser
CytoMed acquires T Cell technology from UK to treat cancers in China and India - BioSpectrum Asia
CytoMed Therapeutics acquires T Cell technology from UK to treat cancers in China and India - BioSpectrum Asia
Applying Wyckoff theory to CytoMed Therapeutics Limited stock2025 Trade Ideas & Weekly Hot Stock Watchlists - newser.com
What earnings margins imply for CytoMed Therapeutics Limited (F98) stockQuarterly Trade Review & AI Driven Stock Movement Reports - newser.com
How CytoMed Therapeutics Limited stock reacts to job market dataPortfolio Update Summary & Daily Technical Stock Forecast Reports - newser.com
Can you recover from losses in CytoMed Therapeutics LimitedTrade Risk Report & AI Driven Stock Reports - newser.com
CytoMed Therapeutics Ltd (GDTC) can make a big difference with a little luck - Setenews
Will CytoMed Therapeutics Limited stock outperform Dow Jones indexJuly 2025 Short Interest & Entry Point Confirmation Alerts - newser.com
Why CytoMed Therapeutics Limited stock remains a top recommendationWatch List & Safe Entry Point Identification - newser.com
CytoMed acquires TC BioPharm’s gamma delta T cell technology By Investing.com - Investing.com Canada
Finanzdaten der Cytomed Therapeutics Ltd-Aktie (GDTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.90%
1.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):